What's Happening?
Berlin Heals Holding AG has successfully raised over $5 million to further develop its novel treatment for heart failure. The company is working on a less invasive approach to implant its device, which uses direct microcurrent to reduce inflammation and remodel the heart. This funding will support the completion of a new study and preparation for future trials, aiming to make the treatment more accessible by eliminating the need for invasive surgery.
Why It's Important?
The development of less invasive treatments for heart failure could significantly improve patient outcomes and accessibility. Berlin Heals' approach may reduce recovery times and expand the availability of treatment to more patients. This advancement reflects a broader trend in the medical field towards minimally invasive procedures, which can lower healthcare costs and improve quality of life for patients.
What's Next?
Berlin Heals plans to complete its current study and prepare for double-blind trials, with the goal of submitting for FDA approval. The company aims to expand its reach by making the treatment available in outpatient settings, potentially transforming heart failure management and increasing its market presence.
